Difference between revisions of "Mapatumumab (HGS-ETR1)"
Jump to navigation
Jump to search
(Created page with "=Mechanism of action= Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) Category:Drug index [[Categ...") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
||
| Line 2: | Line 2: | ||
Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) | Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) | ||
| − | [[Category: | + | [[Category:Drugs]] |
[[Category:Antibody medications]] | [[Category:Antibody medications]] | ||
Revision as of 22:21, 13 June 2018
Mechanism of action
Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1)